Skip to main content

Advertisement

Log in

An Update on Neonatal and Pediatric Conjunctivitis

  • Ocular Therapy (B. Jeng, Section Editor)
  • Published:
Current Ophthalmology Reports Aims and scope Submit manuscript

Abstract

Conjunctivitis is among the most common ophthalmic conditions found in neonatal and pediatric patients. It has a wide range of clinical presentations and outcomes, ranging from self-limiting hyperemia to blindness and life-threatening systemic illness. This review explores the epidemiology, etiology, and diagnosis of conjunctivitis in the neonatal and pediatric population. In addition, it explores recent trends in transmission across different populations and evidence-based approaches that clinicians may use in treating neonatal and pediatric conjunctivitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013;310(16):1721–9. A comprehensive review highlighting recent advancements in diagnosis and management of conjunctivitis with special attention paid to level of evidence for different treatment modalities.

  2. Kakar S, et al. Chlamydia trachomatis causing neonatal conjunctivitis in a tertiary care center. Indian J Med Microbiol. 2010;28(1):45–7.

    Article  CAS  PubMed  Google Scholar 

  3. Schaller UC, Klauss V. Is Credé’s prophylaxis for ophthalmia neonatorum still valid? Bull World Health Organ. 2001;79(3):262–3.

    PubMed Central  CAS  PubMed  Google Scholar 

  4. Wilhelmus KR. Epidemiology of ocular infections. In: Tasman W, Jaeger EA, editors. Duane’s clinical ophthalmology. New York: Lippincott Williams & Wilkins; 2005. p. 1–64.

  5. Ganley JP, Roberts J. Eye conditions and related need for medical care among persons 1-74 years of age, United States 1971-72. In: DHHS, editor. Vital health statistics. Washington: DHHS; 1983.

    Google Scholar 

  6. Laga M, et al. Epidemiology of ophthalmia neonatorum in Kenya. Lancet. 1986;2(8516):1145–9.

    Article  CAS  PubMed  Google Scholar 

  7. Wadhwani M, et al. Conjunctivitis in the newborn—a comparative study. Indian J Pathol Microbiol. 2011;54(2):254–7.

    Article  PubMed  Google Scholar 

  8. Alexandre I, Cortes N, Justel M. The value of simple microbiological studies for on-site screening of acute neonatal conjunctivitis in Angola. J Ophthalmic Inflamm Infect. 2014;4(1):1.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Msukwa G, et al. Maternal and neonatal risk factors associated with vertical transmission of ophthalmia neonatorum in neonates receiving health care in Blantyre, Malawi. Middle East Afr J Ophthalmol. 2014;21(3):240–3.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Richards A, Guzman-Cottrill JA. Conjunctivitis. Pediatr Rev Am Acad Pediatr. 2010;31(5):196–208.

    Article  Google Scholar 

  11. Prevention C.o.D.C.a. STDs in women and infants. 2012.

  12. Brown ZA, et al. Genital herpes complicating pregnancy. Obstet Gynecol. 2005;106(4):845–56.

    Article  PubMed  Google Scholar 

  13. Kimberlin DW, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001;108(2):223–9.

    Article  CAS  PubMed  Google Scholar 

  14. Haas J, et al. Epidemiology and diagnosis of hospital-acquired conjunctivitis among neonatal intensive care unit patients. Pediatr Infect Dis J. 2005;24(7):586–9.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Chhabra MS, Motley Iii WW, Mortensen JE. Eikenella corrodens as a causative agent for neonatal conjunctivitis. J Am Assoc Pediatr Ophthalmol Strabismus. 2008;12(5):524–5.

    Article  Google Scholar 

  16. Mannis MJ, Plotnick RD. Bacterial Conjunctivitis. In: Tasman W, Jaeger EA, editors. Duane’s Clinical Ophthalmology on CD-ROM. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 5.1–5.7.

    Google Scholar 

  17. Høvding G. Acute bacterial conjunctivitis. Acta Ophthalmol. 2008;86(1):5–17.

    Article  PubMed  Google Scholar 

  18. Barquet N, et al. Primary meningococcal conjunctivitis: report of 21 patients and review. Rev Infect Dis. 1990;12(5):838–47.

    Article  CAS  PubMed  Google Scholar 

  19. Wright KW, Spiegel PH, editors. Pediatric ophthalmology and strabismus. 2nd ed. New York: Springer; 2003.

    Google Scholar 

  20. Laga M, et al. Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone. N Engl J Med. 1986;315(22):1382–5.

    Article  CAS  PubMed  Google Scholar 

  21. Matejcek A, Goldman RD. Treatment and prevention of ophthalmia neonatorum. Canadian family physician Médecin de famille canadien. 2013;59(11):1187–90.

    PubMed Central  PubMed  Google Scholar 

  22. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep, 2006. 55(RR-11): p. 1-94.

  23. Kowalski RP, et al. The verification of nucleic acid amplification testing (Gen-Probe Aptima Assay) for chlamydia trachomatis from ocular samples. Ophthalmology. 2015;122(2):244–7.

    Article  PubMed  Google Scholar 

  24. CDC. Sexually transmitted diseases treatment guidelines. Public Health Service Publication; 2002.

  25. Hammerschlag MR, et al. Treatment of neonatal chlamydial conjunctivitis with azithromycin. Pediatr Infect Dis J. 1998;17(11):1049.

    Article  CAS  PubMed  Google Scholar 

  26. Gerstenblith AT, Rabinowitz MP. The Wills eye manual: office and emergency room diagnosis and treatment of eye disease. 6th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2012,. Xix. 471 p.

  27. Zar PHJ. Neonatal chlamydial infections. Pediatr Drugs. 2005;7(2):103–10.

    Article  Google Scholar 

  28. Schwartz GS, Holland EJ. Oral acyclovir for the management of herpes simplex virus keratitis in children. Ophthalmology. 2000;107(2):278–82.

    Article  CAS  PubMed  Google Scholar 

  29. Richards A, Guzman-Cottrill JA. Conjunctivitis. Pediatr Rev. 2010;31(5):196–208. Well-written discussion of the most common etiologies of conjunctivitis in various age groups and clinical manifestations.

  30. Melvin I, Roat MD. Corneal disorders. In: Herpes Simplex Keratitis. Merk Manual Professional version, online version.

  31. Tarabishy AB, et al. Bacterial culture isolates from hospitalized pediatric patients with conjunctivitis. Am J Ophthalmol. 2006;142(4):678–80.

    Article  PubMed  Google Scholar 

  32. Borer A, et al. Hospital-acquired conjunctivitis in a neonatal intensive care unit: bacterial etiology and susceptibility patterns. Am J Infect Control. 2010;38(8):650–2.

    Article  PubMed  Google Scholar 

  33. Crede CSR. Die verhuntuna der augenentzundung der neugeboren. Arch Gynocol. 1881;18:367–70.

    Article  Google Scholar 

  34. Nishida H, Risemberg HM. Silver nitrate ophthalmic solution and chemical conjunctivities. Pediatrics. 1975;56(3):368–73.

    CAS  PubMed  Google Scholar 

  35. Jackson WB, et al. Treatment of acute bacterial conjunctivitis: 1 % fusidic acid viscous drops vs. 0.3 % tobramycin drops. Can J Ophthalmol. 2002;37(4):228–37; discussion 237.

    Article  PubMed  Google Scholar 

  36. Isenberg SJ, Apt L, Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. N Engl J Med. 1995;332(9):562–6.

    Article  CAS  PubMed  Google Scholar 

  37. Caserta MD. Neonatal conjunctivitis. In: Infections in neonates. Merk Manual; 2013.

  38. David M, Rumelt S, Weintraub Z. Efficacy comparison between povidone iodine 2.5 % and tetracycline 1 % in prevention of ophthalmia neonatorum. Ophthalmology. 2011;18(7):1454–8.

    Google Scholar 

  39. Ibhanesebhor SE, Otobo ES. In vitro activity of human milk against the causative organisms of ophthalmia neonatorum in Benin City, Nigeria. J Trop Pediatr. 1996;42(6):327–9.

    Article  CAS  PubMed  Google Scholar 

  40. Ghaemi S, et al. Evaluation of preventive effects of colostrum against neonatal conjunctivitis: a randomized clinical trial. J Educ Health Promot. 2014;3:63.

    PubMed Central  PubMed  Google Scholar 

  41. World Health Organisation. Global prevalence and incidence of selected curable sexually transmitted diseases: overview and estimates. Geneva: WHO; 1999.

    Google Scholar 

  42. Rose P. Management strategies for acute infective conjunctivitis in primary care: a systematic review. Expert Opin Pharmacother. 2007;8(12):1903–21.

    Article  CAS  PubMed  Google Scholar 

  43. Kowalski RP, Dhaliwal DK. Ocular bacterial infections: current and future treatment options. Expert Rev Anti Infect Ther. 2005;3(1):131–9.

    Article  CAS  PubMed  Google Scholar 

  44. Hovding G. Acute bacterial conjunctivitis. Acta Ophthalmol. 2008;86(1):5–17.

    Article  PubMed  Google Scholar 

  45. Meltzer JA, Kunkov S, Crain EF. Identifying children at low risk for bacterial conjunctivitis. Arch Pediatr Adolesc Med. 2010;164(3):263–7.

    Article  PubMed  Google Scholar 

  46. Block SL, et al. Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998). Antimicrob Agents Chemother. 2000;44(6):1650–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. Buznach N, Dagan R, Greenberg D. Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr Infect Dis J. 2005;24(9):823–8.

    Article  PubMed  Google Scholar 

  48. Gigliotti F, et al. Etiology of acute conjunctivitis in children. J Pediatr. 1981;98(4):531–6.

    Article  CAS  PubMed  Google Scholar 

  49. Weiss A, Brinser JH, Nazar-Stewart V. Acute conjunctivitis in childhood. J Pediatr. 1993;122(1):10–4.

    Article  CAS  PubMed  Google Scholar 

  50. Chung CW, Cohen EJ. Eye disorders: bacterial conjunctivitis. West J Med. 2000;173(3):202–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  51. Rubenstein JB, Jick SL. Disorders of the conjunctiva and limbus. In: Yanoff M, Duker JS, editors. Ophthalmology. Missouri: Mosby; 2006. p. 397.

    Google Scholar 

  52. Teoh DL, Reynolds S. Diagnosis and management of pediatric conjunctivitis. Pediatr Emerg Care. 2003;19(1):48–55.

    Article  PubMed  Google Scholar 

  53. Sheikh A, Hurwitz B. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2006;2:CD001211.

  54. Karpecki P, Paterno MR, Comstock TL. Limitations of current antibiotics for the treatment of bacterial conjunctivitis. Optom Vis Sci. 2010;87(11):908–19.

    Article  PubMed  Google Scholar 

  55. Bradley JS, et al. The use of systemic and topical fluoroquinolones. Pediatrics. 2011;128(4):e1034–45.

    Article  PubMed  Google Scholar 

  56. Kowalski RP, Karenchak LM, Romanowski EG. Infectious disease: changing antibiotic susceptibility. Ophthalmol Clin N Am. 2003;16(1):1–9.

    Article  Google Scholar 

  57. Wagner RS, et al. Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue. Arch Ophthalmol. 2005;123(9):1282–3.

    Article  PubMed  Google Scholar 

  58. Tabbara K, El-Asrar AMMA, Khairallah M. Ocular Infections. Berlin: Springer; 2014.

    Book  Google Scholar 

  59. Yeung SN, Butler A, Mackenzie PJ. Applications of the polymerase chain reaction in clinical ophthalmology. Can J Ophthalmol. 2009;44(1):23–30.

    Article  PubMed  Google Scholar 

  60. Elnifro EM, et al. Multiplex polymerase chain reaction for diagnosis of viral and chlamydial keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2000;41(7):1818–22.

    CAS  PubMed  Google Scholar 

  61. O’Brien TP, et al. Acute conjunctivitis: truth and misconceptions. Curr Med Res Opin. 2009;25(8):1953–61.

    Article  PubMed  Google Scholar 

  62. Wagner RS. The differential diagnosis of the red eye. Contemp Pediatr. 1991:1–10.

  63. Donahue SP, Khoury JM, Kowalski RP. Common ocular infections. A prescriber’s guide. Drugs. 1996;52(4):526–40.

    Article  CAS  PubMed  Google Scholar 

  64. Mahmood AR, Narang AT. Diagnosis and management of the acute red eye. Emerg Med Clin N Am. 2008;26(1):35–55 vi.

    Article  Google Scholar 

  65. Sambursky R, et al. The RPS adeno detector for diagnosing adenoviral conjunctivitis. Ophthalmology. 2006;113(10):1758–64.

    Article  PubMed  Google Scholar 

  66. Kim SY, et al. Oral steroid therapy as an adjuvant treatment for severe epidemic keratoconjunctivitis in patients younger than 3 years. Cornea. 2015;34(2):182–7.

    Article  PubMed  Google Scholar 

  67. Liu S, Pavan-Langston D, Colby KA. Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes. Ophthalmology. 2012;119(10):2003–8.

    Article  PubMed  Google Scholar 

  68. •• La Rosa M, et al. Allergic conjunctivitis: a comprehensive review of the literature. Ital J Pediatr. 2013;39:18. A thorough review of allergic conjunctivitis highlighting the various forms, recent trends in diagnosis and treatment options.

  69. Geraldini M, et al. 359 Prevalence of allergic conjunctivitis in childhood. World Allergy Organ J. 2012;5(Suppl 2):S115.

    Article  Google Scholar 

  70. Bielory L, Frohman LP. Allergic and immunologic disorders of the eye. J Allergy Clin Immunol. 1992;89(1 Pt 1):1–15.

    Article  CAS  PubMed  Google Scholar 

  71. Leonardi A, De Dominicis C, Motterle L. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities. Curr Opin Allergy Clin Immunol. 2007;7(5):429–35.

    Article  CAS  PubMed  Google Scholar 

  72. Cronau H, Kankanala RR, Mauger T. Diagnosis and management of red eye in primary care. Am Fam Physician. 2010;81(2):137–44.

    PubMed  Google Scholar 

  73. Friedlaender MH. Ocular allergy. Curr Opin Allergy Clin Immunol. 2011;11(5):477–82.

    Article  CAS  PubMed  Google Scholar 

  74. Bonini S. Atopic keratoconjunctivitis. Allergy. 2004;59(Suppl 78):71–3.

    Article  PubMed  Google Scholar 

  75. Leonardi S, et al. Atopic disease, immune system, and the environment. Allergy Asthma Proc. 2007;28(4):410–7.

    Article  CAS  PubMed  Google Scholar 

  76. Yaylali V, et al. Comparative study of 0.1 % olopatadine hydrochloride and 0.5 % ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis. Acta Ophthalmol Scand. 2003;81(4):378–82.

    Article  CAS  PubMed  Google Scholar 

  77. Pacharn P, Vichyanond P. Immunomodulators for conjunctivitis. Curr Opin Allergy Clin Immunol. 2013;13(5):550–7.

    Article  CAS  PubMed  Google Scholar 

  78. Greiner JV, Udell IJ. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model. Clin Ther. 2005;27(5):568–77.

    Article  CAS  PubMed  Google Scholar 

  79. Forister JF, et al. Prevalence of contact lens-related complications: UCLA contact lens study. Eye Contact Lens. 2009;35(4):176–80.

    Article  PubMed  Google Scholar 

  80. Zicari AM, et al. Serum levels of IL-17 in patients with vernal keratoconjunctivitis: a preliminary report. Eur Rev Med Pharmacol Sci. 2013;17(9):1242–4.

    CAS  PubMed  Google Scholar 

  81. Jun J, Bielory L, Raizman MB. Vernal conjunctivitis. Immunol Allergy Clin N Am. 2008;28(1):59–82 vi.

    Article  Google Scholar 

  82. Kumar S. Vernal keratoconjunctivitis: a major review. Acta Ophthalmol. 2009;87(2):133–47.

    Article  CAS  PubMed  Google Scholar 

  83. Mantelli F, et al. Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. Br J Ophthalmol. 2007;91(12):1656–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  84. Pattnaik L, Acharya L. A comprehensive review on vernal keratoconjunctivitis with emphasis on proteomics. Life Sci. 2015;128:47–54.

    Article  CAS  PubMed  Google Scholar 

  85. Hung SI, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics. 2006;16(4):297–306.

    Article  CAS  PubMed  Google Scholar 

  86. Son MB, Newburger JW. Kawasaki disease. Pediatr Rev. 2013;34(4):151–62.

    Article  PubMed  Google Scholar 

  87. Filipovich AH, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transpl. 2005;11(12):945–56.

    Article  Google Scholar 

  88. Tripathy S, Jiang RH. Massively parallel sequencing technology in pathogenic microbes. Methods Mol Biol. 2012;835(Chapter 17):271–94.

    Article  CAS  PubMed  Google Scholar 

  89. Gui J, Patel IR. Recent advances in molecular technologies and their application in pathogen detection in foods with particular reference to yersinia. J Pathog. 2011;2011(2):310135.

    PubMed Central  PubMed  Google Scholar 

  90. Taravati P, Lam D, Van Gelder RN. Role of molecular diagnostics in ocular microbiology. Curr Ophthalmol Rep. 2013;1(4):181–9.

    Article  Google Scholar 

  91. Gonzalez-Lopez JJ, Morcillo-Laiz R, Munoz-Negrete FJ. Adenoviral keratoconjunctivitis: an update. Arch Soc Esp Oftalmol. 2013;88(3):108–15.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Moran Levin.

Additional information

This article is part of the Topical Collection on Ocular Therapy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Andalibi, S., Haidara, M., Bor, N. et al. An Update on Neonatal and Pediatric Conjunctivitis. Curr Ophthalmol Rep 3, 158–169 (2015). https://doi.org/10.1007/s40135-015-0080-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40135-015-0080-x

Keywords

Navigation